Downstream Processing Market Future Prospects
The global downstream processing market revenue is valued at USD 32.8 billion in 2024, which is projected to advance at a CAGR of 14.6% during 2025–2032, to reach USD 98.6 billion by 2032. This is ascribed to factors such as the biotechnology sector expanding globally, rapid rise in R&D investment in the biopharmaceutical sector, and contract manufacturing organizations gaining significance. Furthermore, there have been incredible opportunities in the biotechnology industry, which have accelerated the expansion of the market on a global level.
Moreover, the rising demand for bioproducts, the growing adoption of biotech processes in the agricultural, pharmaceutical, and bio-services industries, the increasing adoption of single-use technology in bioprocessing, the surging advancements in the fields of gene therapy and genetic engineering, and the growing commercial success of biopharma companies are all contributing to the market growth. In addition, the increasing patent expiration of prominent biopharmaceuticals will generate new possibilities for the downstream processing industry throughout the forecast period.